Jonathan C. Cohen

发表

WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data

Ming Yi, Robert M. Stephens, Jay D. Horton, 2006, BMC Bioinformatics.

A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol.

Jonathan C. Cohen, I. Kotowski, A. Pertsemlidis, 2006, American journal of human genetics.

Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels.

Jonathan C. Cohen, S. Grundy, A. Pertsemlidis, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol

Jonathan C. Cohen, A. Pertsemlidis, H. Hobbs, 2004, Science.

Human Fatty Liver Disease: Old Questions and New Insights

Jonathan C. Cohen, H. Hobbs, J. Horton, 2011, Science.

A Common Allele on Chromosome 9 Associated with Coronary Heart Disease

Jonathan C. Cohen, D. Cox, E. Boerwinkle, 2007, Science.

GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5

Jonathan C. Cohen, D. Srivastava, R. Matsuoka, 2003, Nature.

Lack of MEF2A mutations in coronary artery disease.

Jonathan C. Cohen, Wendy S. Schackwitz, L. Pennacchio, 2005, The Journal of clinical investigation.

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.

Jonathan C. Cohen, E. Boerwinkle, H. Hobbs, 2006, The New England journal of medicine.

Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia.

Jonathan C. Cohen, M. DePristo, E. Banks, 2010, The New England journal of medicine.

Molecular characterization of proprotein convertase subtilisin/kexin type 9-mediated degradation of the LDLR

Jonathan C. Cohen, H. Hobbs, Yan Wang, 2012, Journal of Lipid Research.

Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion1[S]

Jonathan C. Cohen, H. Hobbs, J. Gromada, 2015, Journal of Lipid Research.

Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity

Jonathan C. Cohen, S. Grundy, H. Hobbs, 2004, Hepatology.

Sterol Intermediates from Cholesterol Biosynthetic Pathway as Liver X Receptor Ligands*

Jonathan C. Cohen, Helen H. Hobbs, Yuan Zhang, 2006, Journal of Biological Chemistry.

A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis

Nick V. Grishin, Jonathan C. Cohen, Helen H. Hobbs, 2009, The Journal of Biological Chemistry.

Sequence Variations in PCSK 9 , Low LDL , and Protection against Coronary Heart Disease

Eric Boerwinkle, Jonathan C. Cohen, Helen H. Hobbs, 2006 .

Simple Genetics for a Complex Disease

Jonathan C. Cohen, Helen H. Hobbs, H. Hobbs, 2013, Science.

Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote.

Jonathan C. Cohen, Lisa Kinch, N. Grishin, 2006, American journal of human genetics.

Targeted Deletion of the 9p21 Noncoding Coronary Artery Disease Risk Interval in Mice

Jonathan C. Cohen, A. Visel, L. Pennacchio, 2010, Nature.

ANGPTL8/Betatrophin Does Not Control Pancreatic Beta Cell Expansion

Jonathan C. Cohen, H. Hobbs, S. Bonner-Weir, 2014, Cell.

Atypical angiopoietin-like protein that regulates ANGPTL3

Jonathan C. Cohen, N. Grishin, E. Boerwinkle, 2012, Proceedings of the National Academy of Sciences.

Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis

Jonathan C. Cohen, H. Hobbs, J. Gromada, 2013, Proceedings of the National Academy of Sciences.

ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance[S]

Jonathan C. Cohen, H. Hobbs, A. Murphy, 2017, Journal of Lipid Research.

ANGPTL8 Blockade With a Monoclonal Antibody Promotes Triglyceride Clearance, Energy Expenditure, and Weight Loss in Mice

Jonathan C. Cohen, H. Hobbs, A. Murphy, 2017, Endocrinology.

Hepatic ANGPTL3 regulates adipose tissue energy homeostasis

Jonathan C. Cohen, H. Hobbs, J. Gromada, 2015, Proceedings of the National Academy of Sciences.

Identification by whole-genome resequencing of gene defect responsible for severe hypercholesterolemia

Jay Shendure, Jonathan C. Cohen, Helen H. Hobbs, 2010, Human molecular genetics.

Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis.

Jonathan C. Cohen, H. Hobbs, H. Brown, 2012, The Journal of clinical investigation.

Expression and Characterization of a PNPLA3 Protein Isoform (I148M) Associated with Nonalcoholic Fatty Liver Disease*

Jonathan C. Cohen, H. Hobbs, Yongcheng Huang, 2011, The Journal of Biological Chemistry.

Genetic Approaches to Coronary Heart Disease

Jonathan C. Cohen, 2006 .

Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease

Anne Tybjærg-Hansen, Børge G. Nordestgaard, Jonathan C. Cohen, 2014, Nature Genetics.

Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol.

Jonathan C. Cohen, R. Hammer, H. Hobbs, 2002, The Journal of clinical investigation.

Relative roles of ABCG5/ABCG8 in liver and intestine[S]

Jonathan C. Cohen, H. Hobbs, Matthew A. Mitsche, 2015, Journal of Lipid Research.

Purification and reconstitution of sterol transfer by native mouse ABCG5 and ABCG8.

Jonathan C. Cohen, H. Hobbs, Y. Lei, 2008, Biochemistry.

Ezetimibe normalizes metabolic defects in mice lacking ABCG5 and ABCG8 Published, JLR Papers in Press, June 1, 2005. DOI 10.1194/jlr.M500124-JLR200

Jonathan C. Cohen, H. Hobbs, Liqing Yu, 2005, Journal of Lipid Research.

ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile Published, JLR Papers in Press, June 1, 2005. DOI 10.1194/jlr.M500115-JLR200

Jonathan C. Cohen, H. Hobbs, Liqing Yu, 2005, Journal of Lipid Research.

Selective sterol accumulation in ABCG5/ABCG8-deficient mice Published, JLR Papers in Press, December 1, 2003. DOI 10.1194/jlr.M300377-JLR200

Jonathan C. Cohen, H. Hobbs, Liqing Yu, 2004, Journal of Lipid Research.

Stimulation of Cholesterol Excretion by the Liver X Receptor Agonist Requires ATP-binding Cassette Transporters G5 and G8*

Jonathan C. Cohen, H. Hobbs, Liqing Yu, 2003, The Journal of Biological Chemistry.

Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface.

Jonathan C. Cohen, H. Hobbs, I. Gelissen, 2002, The Journal of clinical investigation.

Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8.

Jonathan C. Cohen, S. Grundy, H. Hobbs, 2002, Journal of lipid research.

The Modular Adaptor Protein ARH Is Required for Low Density Lipoprotein (LDL) Binding and Internalization but Not for LDL Receptor Clustering in Coated Pits*

Jonathan C. Cohen, Richard G. W. Anderson, H. Hobbs, 2004, Journal of Biological Chemistry.

Adiposity Amplifies the Genetic Risk of Fatty Liver Disease Conferred by Multiple Loci

Jonathan C. Cohen, H. Hobbs, B. Nordestgaard, 2017, Nature Genetics.

Flux analysis of cholesterol biosynthesis in vivo reveals multiple tissue and cell-type specific pathways

Jonathan C. Cohen, H. Hobbs, J. McDonald, 2015, eLife.

Increased thermogenesis by a noncanonical pathway in ANGPTL3/8-deficient mice

Jonathan C. Cohen, H. Hobbs, J. Gromada, 2018, Proceedings of the National Academy of Sciences.

Identification of a VLDL‐induced, FDNPVY‐independent internalization mechanism for the LDLR

Jonathan C. Cohen, H. Hobbs, Wei-ping Li, 2007, The EMBO journal.

Sequences in the Nonconsensus Nucleotide-binding Domain of ABCG5/ABCG8 Required for Sterol Transport*

Jonathan C. Cohen, N. Grishin, H. Hobbs, 2011, The Journal of Biological Chemistry.

Endothelial lipase: direct evidence for a role in HDL metabolism.

Jonathan C. Cohen, 2003, The Journal of clinical investigation.

Endothelial lipase: direct evidence for a role in HDL metabolism

Jonathan C. Cohen, 2003 .

The Modular Adaptor Protein Autosomal Recessive Hypercholesterolemia (ARH) Promotes Low Density Lipoprotein Receptor Clustering into Clathrin-coated Pits*

Jonathan C. Cohen, H. Hobbs, R. Gerard, 2005, Journal of Biological Chemistry.

Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis

Jonathan C. Cohen, H. Hobbs, J. Gromada, 2014, Hepatology.

Inactivation of Tm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins*

Jonathan C. Cohen, H. Hobbs, S. Gilyard, 2016, The Journal of Biological Chemistry.

Lipoprotein(a) and Apolipoprotein(a) Isoforms: No Association With Coronary Artery Calcification in The Dallas Heart Study

Jonathan C. Cohen, H. Hobbs, Zhaoxia Yu, 2005, Circulation.

Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans.

Eric Boerwinkle, Len A Pennacchio, Jonathan C. Cohen, 2008, The Journal of clinical investigation.

Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance

Jonathan C. Cohen, H. Hobbs, A. Murphy, 2020, Journal of Lipid Research.

Genetic Variation in ANGPTL4 Provides Insights into Protein Processing and Function

Jonathan C. Cohen, N. Grishin, H. Hobbs, 2009, Journal of Biological Chemistry.

APOC3, coronary disease, and complexities of Mendelian randomization.

Jonathan C. Cohen, H. Hobbs, S. Stender, 2014, Cell metabolism.

Genetic variant in PNPLA3 is associated with nonalcoholic fatty liver disease in China

Jonathan C. Cohen, H. Hobbs, C. Xing, 2012, Hepatology.

Angiopoietin-like protein 3 (ANGPTL3) governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance

Jonathan C. Cohen, H. Hobbs, A. Murphy, 2020 .

Mutations in ATP‐cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia

Jonathan C. Cohen, H. Hobbs, J. Hubacek, 2001, Human mutation.

Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptor

Jonathan C. Cohen, H. Hobbs, R. Garuti, 2008, Proceedings of the National Academy of Sciences.

No Association Between Plasma Levels of Plant Sterols and Atherosclerosis in Mice and Men

Jonathan C. Cohen, S. Grundy, G. Vega, 2004, Arteriosclerosis, thrombosis, and vascular biology.

Patatin‐like phospholipase domain‐containing 3 and the pathogenesis and progression of pediatric nonalcoholic fatty liver disease

Jonathan C. Cohen, H. Hobbs, J. Browning, 2010, Hepatology.

Homozygosity mapping identifies a bile acid biosynthetic defect in an adult with cirrhosis of unknown etiology

Jonathan C. Cohen, H. Hobbs, C. Xing, 2012, Hepatology.

High-level expression of ABCG5 and ABCG8 attenuates diet-induced hypercholesterolemia and atherosclerosis in Ldlr (cid:2) / (cid:2) mice

Jonathan C. Cohen, H. Hobbs, Liqing Yu, 2004 .

Dual roles for cholesterol in mammalian cells.

Jonathan C. Cohen, H. Hobbs, R. B. Rawson, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Molecular mechanisms of autosomal recessive hypercholesterolemia.

Jonathan C. Cohen, H. Hobbs, J. Garcia, 2002, Human molecular genetics.

HSD17B13 and Chronic Liver Disease in Blacks and Hispanics.

Jonathan C. Cohen, H. Hobbs, S. Stender, 2018, The New England journal of medicine.

Functional Asymmetry of Nucleotide-binding Domains in ABCG5 and ABCG8*

Jonathan C. Cohen, H. Hobbs, R. Gerard, 2006, Journal of Biological Chemistry.

Patatin-like phospholipase domain–containing protein 3 promotes transfers of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets.

Jonathan C. Cohen, H. Hobbs, Michael A. Mitsche, 2018, The Journal of Biological Chemistry.

Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels.

Jonathan C. Cohen, R. Krauss, M. Olivier, 2002, Human molecular genetics.

Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysis

Jonathan C. Cohen, H. Hobbs, N. Glorioso, 2002, The Lancet.

No association between polymorphism in PEMT (V175M) and hepatic triglyceride content in the Dallas Heart Study

Jonathan C. Cohen, H. Hobbs, S. Romeo, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion

Jonathan C. Cohen, R. Hammer, H. Hobbs, 2002, Proceedings of the National Academy of Sciences of the United States of America.

ABCG5 and ABCG8 Are Obligate Heterodimers for Protein Trafficking and Biliary Cholesterol Excretion*

Jonathan C. Cohen, H. Hobbs, R. Gerard, 2003, Journal of Biological Chemistry.

Relationship between genetic variation at PPP1R3B and levels of liver glycogen and triglyceride

Jonathan C. Cohen, D. Dickel, L. Pennacchio, 2018, Hepatology.

ARH Is a Modular Adaptor Protein That Interacts with the LDL Receptor, Clathrin, and AP-2*

Jonathan C. Cohen, H. Hobbs, Ming Yi, 2002, The Journal of Biological Chemistry.

Autosomal Recessive Hypercholesterolemia Caused by Mutations in a Putative LDL Receptor Adaptor Protein

Jonathan C. Cohen, N. Grishin, H. Hobbs, 2001, Science.

Adult-onset liver disease and hepatocellular carcinoma in S-adenosylhomocysteine hydrolase deficiency.

Jonathan C. Cohen, H. Hobbs, C. Xing, 2015, Molecular genetics and metabolism.

Variability of cholesterol accessibility in human red blood cells measured using a bacterial cholesterol-binding toxin

Jonathan C. Cohen, H. Hobbs, J. Kozlitina, 2017, eLife.

Patatin-like phospholipase domain–containing protein 3 promotes transfers of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets

Jonathan C. Cohen, H. Hobbs, Matthew A. Mitsche, 2018, The Journal of Biological Chemistry.

Dissociation Between APOC3 Variants, Hepatic Triglyceride Content and Insulin Resistance

Jonathan C. Cohen, E. Boerwinkle, H. Hobbs, 2011, Hepatology.

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

Alexander Pertsemlidis, Eric Boerwinkle, Chao Xing, 2008, Nature Genetics.

Medical sequencing at the extremes of human body mass.

Roded Sharan, Eytan Ruppin, Nir Yosef, 2006, American journal of human genetics.

An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing

Jonathan C. Cohen, D. Cox, R. Krauss, 2001, Science.

Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL

Eric Boerwinkle, Yunxin Fu, Len A Pennacchio, 2007, Nature Genetics.

Mendelian disorders and multifactorial traits: the big divide or one for all?

Jonathan C. Cohen, A. Chakravarti, J. Hardy, 2010, Nature Reviews Genetics.

Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis

Jonathan C. Cohen, H. Hobbs, Yang Wang, 2019, Proceedings of the National Academy of Sciences.

Functional characterization of genetic variants in NPC1L1 supports the sequencing extremes strategy to identify complex trait genes

Jonathan C. Cohen, H. Hobbs, Saleemah Fahmi, 2008, Human molecular genetics.

Deletion of GPIHBP1 causing severe chylomicronemia

Jonathan C. Cohen, H. Hobbs, N. Hauser, 2011, Journal of Inherited Metabolic Disease.

High-level expression of ABCG5 and ABCG8 attenuates diet-induced hypercholesterolemia and atherosclerosis in Ldlr−/− mice Published, JLR Papers in Press, June 1, 2004. DOI 10.1194/jlr.M400167-JLR200

Jonathan C. Cohen, H. Hobbs, Liqing Yu, 2004, Journal of Lipid Research.

Common single-nucleotide polymorphisms act in concert to affect plasma levels of high-density lipoprotein cholesterol.

Jonathan C. Cohen, S. Schmidt, S. Sunyaev, 2007, American journal of human genetics.

Molecular mechanisms of autosomal recessive hypercholesterolemia

Jonathan C. Cohen, H. Hobbs, M. Kimmel, 2003, Current opinion in lipidology.

Molecular basis of cholesterol efflux via ABCG subfamily transporters

Jonathan C. Cohen, H. Hobbs, Xiaochun Li, 2021, Proceedings of the National Academy of Sciences.

Crystal structure of the human sterol transporter ABCG5/ABCG8

Jonathan C. Cohen, H. Hobbs, L. Kinch, 2016, Nature.

Binding of Proprotein Convertase Subtilisin/Kexin Type 9 to Epidermal Growth Factor-like Repeat A of Low Density Lipoprotein Receptor Decreases Receptor Recycling and Increases Degradation*

Jonathan C. Cohen, H. Hobbs, J. Horton, 2007, Journal of Biological Chemistry.

Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface

Jonathan C. Cohen, H. Hobbs, I. Gelissen, 2002 .

ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys1[S]

Jonathan C. Cohen, H. Hobbs, A. Murphy, 2015, Journal of Lipid Research.

Hepatic TM6SF2 Is Required for Lipidation of VLDL in a Pre-Golgi Compartment in Mice and Rats

Jonathan C. Cohen, H. Hobbs, S. Martin, 2021, Cellular and molecular gastroenterology and hepatology.

A Protein‐Truncating HSD17B13 Variant and Protection from Chronic Liver Disease

Alexander E. Lopez, Tanya M. Teslovich, Alexander Hanbo Li, 2018, The New England journal of medicine.

Genome‐wide Linkage and Association Analyses to Identify Genes Influencing Adiponectin Levels: The GEMS Stud

Jonathan C. Cohen, S. Grundy, R. Mahley, 2009, Obesity.

Adult-onset ornithine transcarbamylase (OTC) deficiency unmasked by the Atkins' diet.

Jonathan C. Cohen, Hanna Mandel, H. Mandel, 2010, Journal of hepatology.

PCSK9: a convertase that coordinates LDL catabolism Published, JLR Papers in Press, November 19, 2008.

Jonathan C. Cohen, H. Hobbs, J. Horton, 2009, Journal of Lipid Research.

A weighted false discovery rate control procedure reveals alleles at FOXA2 that influence fasting glucose levels.

Eric Boerwinkle, Chao Xing, Jonathan C. Cohen, 2010, American journal of human genetics.

Disruption of cholesterol homeostasis by plant sterols.

Jonathan C. Cohen, H. Hobbs, Wei-ping Li, 2004, The Journal of clinical investigation.

Missense Mutations in ABCG5 and ABCG8 Disrupt Heterodimerization and Trafficking*

Jonathan C. Cohen, H. Hobbs, G. Graf, 2004, Journal of Biological Chemistry.

Genetic and Metabolic Determinants of Plasma Levels of ANGPTL8

Jonathan C. Cohen, H. Hobbs, V. Gusarova, 2021, The Journal of clinical endocrinology and metabolism.

An apolipoprotein identified through comparative sequence analysis influences triglyceride levels in humans and mice.

Jonathan C. Cohen, D. Cox, L. Pennacchio, 2001 .

Normal Sorting but Defective Endocytosis of the Low Density Lipoprotein Receptor in Mice with Autosomal Recessive Hypercholesterolemia*

Jonathan C. Cohen, R. Hammer, H. Hobbs, 2003, Journal of Biological Chemistry.

The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation

Jonathan C. Cohen, H. Hobbs, Ē. Šmagris, 2017, Hepatology.

Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: the GEMS Study.

Jonathan C. Cohen, Xiwu Lin, S. Grundy, 2008, Atherosclerosis.

Molecular biology of PCSK9: its role in LDL metabolism.

Jonathan C. Cohen, H. Hobbs, J. Horton, 2007, Trends in biochemical sciences.

Lawrence Berkeley National Laboratory Recent Work Title Relationship between genetic variation at PPP 1 R 3 B and levels of liver glycogen and triglyceride Permalink

Jonathan C. Cohen, D. Dickel, L. Pennacchio, 2018 .

Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia.

Jonathan C. Cohen, H. Hobbs, N. Maeda, 2007, The Journal of clinical investigation.

Missense variant in insulin receptor (Y1355H) segregates in family with fatty liver disease

Jonathan C. Cohen, H. Hobbs, G. Liang, 2021, Molecular metabolism.

ANGPTL8 has both endocrine and autocrine effects on substrate utilization

Jonathan C. Cohen, H. Hobbs, S. Banfi, 2020, JCI insight.

PNPLA3, CGI‐58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice

Jonathan C. Cohen, H. Hobbs, Nora Kory, 2019, Hepatology.

Genetic and metabolic determinants of plasma PCSK9 levels.

Jonathan C. Cohen, H. Hobbs, J. Horton, 2009, The Journal of clinical endocrinology and metabolism.

Lawrence Berkeley National Laboratory Lawrence Berkeley National Laboratory Title Medical Sequencing at the extremes of Human Body Mass Permalink

Jonathan C. Cohen, R. Sharan, S. Schmidt, 2022 .

Indices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatin.

Jonathan C. Cohen, S. Grundy, G. Vega, 2010, The Journal of clinical endocrinology and metabolism.

Expression of ABCG5 and ABCG8 Is Required for Regulation of Biliary Cholesterol Secretion*

Jonathan C. Cohen, H. Hobbs, D. Mangelsdorf, 2005, Journal of Biological Chemistry.

A feed-forward loop amplifies nutritional regulation of PNPLA3

Jonathan C. Cohen, H. Hobbs, T. Osborne, 2010, Proceedings of the National Academy of Sciences.

Sterol Transfer by ABCG5 and ABCG8

Jonathan C. Cohen, H. Hobbs, Da-Wei Zhang, 2006, Journal of Biological Chemistry.

Family history is a major determinant of subclinical peripheral arterial disease in young adults.

Jonathan C. Cohen, R. J. Valentine, R. Guerra, 2004, Journal of vascular surgery.

Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project).

Jonathan C. Cohen, S. Grundy, R. Mahley, 2005, The American journal of cardiology.

Erratum: Patatin-like phospholipase domain-containing protein 3 promotes transfers of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets (Journal of Biological Chemistry (2018) 293 (6958-6968) DOI: 10.1074/jbc.RA118.002333)

Jonathan C. Cohen, H. Hobbs, Michael A. Mitsche, 2018 .

Impaired glycogen breakdown and synthesis in phosphoglucomutase 1 deficiency.

Jonathan C. Cohen, Sun Young Park, R. Haller, 2017, Molecular genetics and metabolism.

Sources of variability in genetic association studies: Insights from the analysis of hepatic lipase (LIPC)

Jonathan C. Cohen, S. Grundy, R. Mahley, 2002, Human mutation.

Emerging LDL therapies: Using human genetics to discover new therapeutic targets for plasma lipids.

Jonathan C. Cohen, 2013, Journal of clinical lipidology.

Overexpression of ABCG 5 and ABCG 8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol

Jonathan C. Cohen, R. Hammer, H. Hobbs, 2018 .

Hepatic triglyceride content in individuals with reduced intestinal cholesterol absorption due to variants in Nieman Pick C1‐like 1

Jonathan C. Cohen, H. Hobbs, R. Ramirez, 2011, Hepatology.

Cloning of the human cholesterol 7 alpha-hydroxylase gene (CYP7) and localization to chromosome 8q11-q12.

Jonathan C. Cohen, H. Hobbs, D. Russell, 1992, Genomics.